Clinical Trials Browser

Phase 2 × epothilone B × Genitourinary × Clear all

NCT00411528 2020-12-17

Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00035113 2017-02-09

EPO906 Therapy in Patients With Prostate Cancer

Phase 2 Completed

Carcinoma, Neoplasms, Prostatic Neoplasms

NCT00035243 2012-04-17

EPO906 Therapy in Patients With Advanced Kidney Cancer

Phase 2 Completed

Carcinoma, Kidney Neoplasms, Neoplasms

NCT00407251 2010-11-05

Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy

Phase 2 Completed

Hormone Refractory Prostate Cancer